APPLICATION
ANDA211003
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-22
LATEST ACTION
2023-09-22
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
LEVOLEUCOVORIN CALCIUMDiscontinued
LEVOLEUCOVORIN CALCIUM EQ 50MG BASE/VIAL · POWDER · INTRAVENOUS
Approval history
2023-09-22Labeling · Supplement 3 · standardAP
2023-09-22Labeling · Supplement 2 · standardAP
2019-08-22UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.